NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-059-2013-0-JP-25 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP DIV 2022-185113 Pending
NIAID E-052-2017-4-MX-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MX DIV MX/a/2022/014631 Pending
NIAID E-238-2020-0-PCT-02 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) PCT PCT PCT/US2022/080015 Expired
NHGRI E-275-2015-0-US-05 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC US DIV 18/056,356 Pending
NIA E-135-2022-1-US-01 MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF US 63/426,275 Expired
NIAID E-128-2021-0-EP-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS EP National Stage 21803062.5 Pending
NCI E-027-2023-0-US-01 REAL-TIME REMOTE CONTROLLED MICROSCOPY AND COMMUNICATIONS OVER A NETWORK US 63/425,888 Expired
NCI E-184-2020-0-US-03 TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS US National Stage 17/925,582 Pending
NIAID E-128-2021-0-US-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS US National Stage 17/998,752 Pending
NLM E-125-2017-2-US-06 CRYSTAL STRUCTURE OF CRISPR CPF1 US CON 17/986,277 Pending
NIAID E-064-2016-1-CN-10 RSV F IMMUNOGENS AND THEIR USE CN DIV 202211420259.2 Pending
NCATS E-101-2017-0-EP-07 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS EP DIV 22207287.8 Pending
NIAID E-171-2021-0-PCT-02 SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN PCT PCT PCT/US2022/079750 Expired
NIAID E-104-2020-0-US-08 RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS US National Stage 17/924,784 Pending
NCI E-219-2022-0-US-01 Circulating MicroRNA (miRNA) Markers To Diagnose Lethal Radiation
(WRAIR 22-05-US01-PR1) 		US 63/424,554 Expired
NICHD E-151-2021-0-PCT-02 NUCLEAR MAGNETIC RESONANCE METHODS OF DETERMINING HOMEOSTATIC
PERTURBATIONS 		PCT PCT PCT/US2022/049542 Expired
NEI E-058-2018-0-US-08 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES (2-D CELLS AND 3-D TISSUES) FOR USE IN CELL THERAPY AND TISSUE ENGINEERED PRODUCTS US CON 17/983,963 12020494 Issued PDF
NCI E-205-2021-0-PCT-02 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF PCT PCT PCT/US2022/079554 Expired
NCI E-205-2021-0-CN-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF CN National Stage 202280088358.7 Pending
NHLBI E-166-2022-0-US-01 MYOTOMY CATHETER SYSTEM AND METHODS FOR A MYOTOMY CATHETER SYSTEM US 63/383,012 Expired
NCI E-017-2023-0-US-01 Directed acetylation of mRNA through engineered snoRNA adapters US 63/423,714 Expired
NCI E-009-2023-0-US-01 Implications of CXCR3 Expression on Myeloid Cells for Immunotherapy of Cancer and Myeloid-mediated Disease US 63/423,029 Expired
NIAID E-095-2021-0-PCT-02 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2022/079340 Expired
NHGRI E-054-2020-0-US-03 ABERRANT POST-TRANSLATIONAL MODIFICATIONS(PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS US National Stage 17/923,394 Pending
NCI E-099-2014-0-JP-01 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2022-177351 Pending
NIAID E-001-2024-0-US-03 Viral Strain Serology Assays US 63/382,391 Expired
NIAID E-153-2023-0-US-01 Rebalancing the Immune System Through Depletion of Myeloid-Biased Hematopoietic Stem Cells US 63/422,765 Expired
NIAID E-149-2022-0-US-01 NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME US 63/422,250 Expired
NIAID E-197-2023-0-US-03 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/381,850 Expired
NIAID E-197-2023-1-US-02 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/381,842 Expired
NCI E-150-2017-2-HK-01 Diagnostic Methods For T Cell Therapy HK CN 42022062958.8 Pending
NCI E-206-2022-0-US-01 T CELL RECEPTORS TARGETING MUTATED CDKN2A US 63/381,591 Expired
NCI E-213-2022-0-US-01 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION US 63/381,587 Expired
NIDCR E-150-2019-0-US-03 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear US National Stage 17/922,300 Pending
NCATS E-004-2016-0-CN-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CN DIV 202211334125.9 Pending
NCATS E-043-2017-3-US-01 Pharmaceutical Compositions With Antiflaviviral Activity US CON 18/050,177 Pending
NICHD E-200-2021-0-PCT-02 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE PCT PCT PCT/US2022/078713 Expired
NIAID E-002-2023-0-US-01 VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US 63/419,637 Expired
NCI E-204-2021-0-PCT-02 SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN PCT PCT PCT/US2022/078632 Expired
NCI E-104-2013-0-US-06 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 18/049,470 Pending
NCI E-234-2014-1-HK-02 METHODS 0F PRODUCTION OF AUTOLOGOUS T CELLS FOR TREATMENT OF B-CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF HK CN 42022062626.1 Pending
NCI E-135-2019-0-HK-17 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 HK EP 62022062662.1 Pending
NIAID E-174-2023-0-US-01 Self-Assembling Nanoparticles US 63/380,931 Expired
NIAID E-025-2023-0-US-01 Combination Treatment For Treating Cancer US 63/380,929 Expired
NIAID E-097-2020-0-KR-09 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE KR National Stage 10-2022-7037236 Pending
NIAID E-297-2016-2-AU-11 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU DIV 2022256195 Issued
NICHD E-072-2017-0-JP-08 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE JP DIV 2022-169032 Issued
NCI E-192-2023-0-PC-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis PCT PCT PCT/EP2022/079286 Expired
NIDDK E-108-2020-0-EP-03 Thyclotides EP National Stage 21723830.2 Pending
NCI E-192-2023-0-TW-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis TW ORD 111139905 Pending